Outcome of Idiopathic Pulmonary Fibrosis With Pregnancy
1 other identifier
observational
63
1 country
1
Brief Summary
case-control study was conducted between December 2018 to April 2020. To document outcome of IPF with pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2021
CompletedFirst Submitted
Initial submission to the registry
February 22, 2021
CompletedFirst Posted
Study publicly available on registry
March 1, 2021
CompletedMarch 1, 2021
February 1, 2021
1.4 years
February 22, 2021
February 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
any adverse events including gestational complication or disease specific complication
e.g (development of respiratory failure, need for ICU admission). maternal outcome
from the start of inclusion to the study till termination of pregnancy, average 9 months period
neonatal outcome
any unfavorable neonatal outcome as low birth weight
December 2018 to April 2020
neonatal outcome
any unfavorable neonatal outcome as prematurity or neonatal death.
December 2018 to April 2020
Study Arms (2)
cases
pregnant female with idiopathic pulmonary fibrosis
control group
pregnant female with bronchial asthma
Eligibility Criteria
Female patients were diagnosed to have IPF of childbearing age, patients were presented during pregnancy
You may qualify if:
- Patients with pulmonary diseases during pregnancy
You may not qualify if:
- Patients with pulmonary diseases other than IPF and bronchial asthma were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag University
Sohag, 82524, Egypt
Related Publications (2)
American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002 Jan 15;165(2):277-304. doi: 10.1164/ajrccm.165.2.ats01. No abstract available.
PMID: 11790668BACKGROUNDSharma CP, Aggarwal AN, Vashisht K, Jindal SK. Successful outcome of pregnancy in idiopathic pulmonary fibrosis. J Assoc Physicians India. 2002 Nov;50:1446-8.
PMID: 12583483BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant professor
Study Record Dates
First Submitted
February 22, 2021
First Posted
March 1, 2021
Study Start
December 1, 2018
Primary Completion
April 30, 2020
Study Completion
February 20, 2021
Last Updated
March 1, 2021
Record last verified: 2021-02